急性脑梗死患者病情及预后与VASH-1、PN、NSE水平的关系研究OA
Study on the relationship between the condition and prognosis of patients with acute cerebral infarction and the levels of VASH-1,NSE,and PN
目的 分析血管生成抑制蛋白-1(VASH-1)、骨膜蛋白(PN)、神经元特异性烯醇化酶(NSE)与急性脑梗死(ACI)患者病情及预后的关系.方法 选取2023年5月—2025年4月首都医科大学附属北京康复医院神经内科收治的ACI患者150例作为研究组,ACI患者根据病情程度分为轻型51例、中型59例、重型40例,根据90 d预后分为预后良好亚组105例与预后不良亚组45例,另选取同期医院健康体检者150例作为健康对照组.Kendall's tau-b相关系数检验血清VASH-1、PN、NSE水平与ACI患者病情程度的相关性;采用受试者工作特征(ROC)曲线分析血清VASH-1、PN、NSE水平评估重型ACI患者的价值;多因素Logistic回归分析血清VASH-1、PN、NSE水平对ACI患者90 d预后的影响.结果 研究组血清VASH-1、PN、NSE水平均高于健康对照组(t/P=51.974/<0.001、23.625/<0.001、44.520/<0.001);血清 VASH-1、PN、NSE 水平比较,重型>中型>轻型 ACI 患者(F/P=61.979/<0.001、115.407/<0.001、81.533/<0.001);预后不良亚组血清 VASH-1、PN、NSE 水平高于预后良好亚组(t/P=11.019/<0.001、11.353/<0.001、13.811/<0.001);血清 VASH-1、PN、NSE 水平均与 ACI 患者病情程度呈正相关(r/P=0.338/0.015、0.409/0.009、0.397/0.011);血清VASH-1、PN、NSE水平单独及三者联合评估重型ACI患者的曲线下面积(AUC)分别为0.854、0.870、0.859、0.881,三者联合优于各自单独评估价值(Z/P=2.114/0.035、1.994/0.048、2.307/0.021);VASH-1 高、PN 高、NSE高是 ACI 患者 90 d 预后不良的独立危险因素[OR(95%CI)=1.018(1.008~1.029)、1.427(1.187~1.715)、1.343(1.178~1.530)].结论 ACI患者血清VASH-1、PN、NSE水平显著升高,且与病情严重程度及预后相关,联合检测三项指标对评估ACI严重程度及预测不良预后均具有重要价值.
Objective To analyze the relationship between vasohibin-1(VASH-1),neuron-specific enolase(NSE),and periostin(PN)levels and the condition and prognosis of patients with acute cerebral infarction(ACI).Methods A total of 150 ACI patients admitted to the Department of Neurology,Beijing Rehabilitation Hospital Affiliated to Capital Medical University from May 2023 to April 2025 were selected as the study group.Patient condition was assessed using the National Institutes of Health Stroke Scale(NIHSS)and categorized as mild(NIHSS score ≤5),moderate(score range 6-15),or se-vere(score ≥ 16).Patients were followed up for 90 days,and short-term prognosis was evaluated using the modified Rankin Scale(mRS),dividing them into a poor prognosis subgroup and a good prognosis subgroup.Additionally,150 healthy individ-uals undergoing physical examinations during the same period were selected as the healthy control group.Serum levels of VASH-1,NSE,and PN were compared among patients with different conditions and prognoses.The relationships between these serum markers and the condition as well as short-term prognosis of ACI patients were analyzed,along with their value in assessing severe ACI and predicting short-term poor prognosis.Results Serum levels of VASH-1,PN,and NSE in the study group were significantly higher than those in the healthy control group(t=51.974,23.625,44.520,all P<0.001).Among the 150 ACI patients,there were 51(34.00%),59(39.33%),and 40(26.67%)patients with mild,moderate,and severe conditions,respectively.Serum levels of VASH-1,PN,and NSE were significantly higher in severe patients than in moderate patients,and significantly higher in moderate patients than in mild patients(F=61.979,115.407,81.533,all P<0.001).Serum levels of VASH-1,PN,and NSE in the poor prognosis subgroup were significantly higher than those in the good prognosis subgroup(t=11.019,11.353,13.811,all P<0.001).Serum levels of VASH-1,PN,and NSE were positively correlated with the severity of ACI patients(r=0.338,0.409,0.397;P=0.015,0.009,0.011,respectively).The AUCs for serum VASH-1,PN,NSE,and their combination in assessing severe ACI patients were 0.854,0.870,0.859,and 0.881,respectively.The combined assessment was superior to each marker alone(differences were compared using DeLong's test)(Z=2.114,1.994,2.307;P=0.035,0.048,0.021,respectively).High expression levels of serum VASH-1,PN,and NSE were independent risk factors for poor prognosis in ACI patients[OR(95%CI)=1.018(1.008-1.029),1.427(1.187-1.715),1.343(1.178-1.530)].Conclusion Serum levels of VASH-1,NSE,and PN are associated with the condition and prognosis of ACI patients.Their individual and combined detection are valuable for assessing severe ACI and predicting poor prognosis.
陈正;王瑞丹;钱树坤;丁磊;刘建华
100144 北京,首都医科大学附属北京康复医院检验科100144 北京,首都医科大学附属北京康复医院神经内科100144 北京,首都医科大学附属北京康复医院检验科100144 北京,首都医科大学附属北京康复医院检验科100144 北京,首都医科大学附属北京康复医院检验科
医药卫生
急性脑梗死血管生成抑制蛋白-1骨膜蛋白神经元特异性烯醇化酶病情预后相关性
Acute cerebral infarctionVasohibin-1PeriostinNeuron-specific enolaseConditionPrognosisCorre-lation
《疑难病杂志》 2026 (4)
440-445,6
首都卫生发展科研专项项目(首发2024-2-2251) Capital's Health Development Scientific Research Special Project(Shoufa 2024-2-2251)
评论